Erratum to: A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors. (Q53194084)
Jump to navigation
Jump to search
scientific article published in December 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Erratum to: A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors. |
scientific article published in December 2015 |
Statements
Erratum to: A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors (English)
Geoffrey I Shapiro
Laurel M Adams
Laurie Sherman
Steve Weller
Suzanne Swann
Harold Keer
Dale Miles
Thomas Müller
Fabiola Cecchi
Patricia LoRusso
1 December 2015